MT Newswires
Altimmune Says US FDA Grants Breakthrough Therapy Designation for Pemvidutide in MASH
📈
AI Sentiment
Highly Positive
9/10
Altimmune Inc. News
Latest updates and market news for ALT
2 news
Jan 1 - Jan 7, 2026
Page 1
Share this news page